II. Safety

  1. Vaccines are safe
    1. Serious Allergic Reaction occur in less than 4 in one million with DTaP Vaccine, MMR Vaccine, Varicella Vaccine
    2. Most pediatric Vaccines do not contain thimerosol (and thimerosol)
    3. Of the 6000 daily antigen exposures daily, a full Primary Series only exposes children to a total of 150 antigens
  2. Vaccines prevent life threatening illness
    1. Tetanus will kill one child in 10 who contract the infection
    2. Measles will kill one child in 1000 who contract the infection
    3. Varicella will kill one older child in 100,000 who contract the infection
  3. Undervaccination puts community health at risk
    1. Undervaccination has been associated with resurgence of Measles
      1. Gahr (2014) Pediatrics 134(1): e220-8 +PMID:24913790 [PubMed]
  4. Vaccine refusal
    1. Listen to concerns without minimizing concerns
    2. Explain risks and benefits
    3. Consider asking parents to sign a "Refusal to Vaccinate"
    4. Consider applying appropriate billing codes
      1. V64.05 Vaccine refusal by caregiver
      2. V64.07 Vaccine refusal for religious reasons
  5. Avoid prophylactic Analgesics and antipyretics at the time of Immunization (per CDC)
    1. Antipyretics do not reduce the risk of Febrile Seizure
    2. Risk of decreased immunogenic response to Vaccination
      1. Prymula (2009) Lancet 374(9698): 1339-50 [PubMed]
  6. References
    1. (2015) Presc Lett 22(3): 13

III. Contraindications: Vaccination

  1. True contraindications to Vaccination
    1. Current moderate to severe illness
    2. Anaphylaxis to Vaccine or Vaccine constituent (see below)
      1. Anaphylaxis to Vaccination is rare (<1 in one million doses)
      2. Obtain immediate type allergy Skin Testing if Vaccination is suspected for severe allergy or Anaphylaxis
  2. Conditions that do not contraindicate Vaccine
    1. Moderate inflammation at prior Immunization site
    2. Moderate fever following prior Vaccination
    3. Current antibiotic usage
    4. Recovering from illness or recent exposure to illness
    5. Prematurity (no change in dosage)
    6. Unvaccinated household contact
    7. Pregnancy of household contact

IV. Precautions: Vaccine Additives

  1. Potential allergans for those with known Anaphylaxis to these agents
  2. Neomycin
    1. Varicella Vaccine
    2. Measles Mumps Rubella Vaccine (MMR Vaccine)
    3. Inactivated Polio Vaccine
  3. Gelatin
    1. Varicella
    2. Measles Mumps Rubella Vaccine (MMR Vaccine)
  4. Egg protein
    1. Inactivated Influenza Vaccine (use egg-free trivalent Inactivated Influenza Vaccine instead)
    2. Egg allergy is not a contraindication to Measles Mumps Rubella Vaccine (MMR Vaccine)
  5. Thimerisal
    1. Preservative in Vaccinations used since 1930s
    2. Contains small amount of Mercury, but no association with any neurologic disorder including Autism
    3. Removed from all Vaccinations in U.S. except for multi-dose Inactivated Influenza Vaccine
  6. Latex
    1. Infarix (DTaP Vaccine)
    2. Menomune, Bexsero (Meningococcal Vaccine)
    3. Rotarix (Rotavirus Vaccine oral applicator)

VI. Precautions: Maintaining Vaccine efficacy

  1. Maintain the cold chain prior to Vaccine administration
    1. Most Vaccines must be maintained in a tightly Temperature controlled refrigerator to ensure Vaccine efficacy
  2. Consider a back-up generator to protect Vaccines if power fails
  3. Manufacturers can give guidance if vaccine Temperatures varied from those recommended
  4. Use a refrigerator designed for Vaccines
  5. Monitor refrigerator Temperature twice daily or more with buffered probe thermometer (e.g. glycol-encased)
    1. Continuous monitoring and automatic recording is preferred
    2. Thermometer ideally alarms when Temperature falls out of safe range
  6. Keep Vaccines on the middle of the shelves (not in the door or along the back wall) to maintain consistent Temperature
  7. Water bottles or freezer packs can help stabilize the Temperature (but do not store food with Vaccines)
  8. References
    1. (2012) Presc Lett 19(12): 70

Images: Related links to external sites (from Bing)

Related Studies (from Trip Database) Open in New Window

Ontology: Vaccination (C0042196)

Definition (NCI_NCI-GLOSS) Treatment with a vaccine.
Definition (NCI) Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis or treatment.
Definition (MSH) Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.
Concepts Therapeutic or Preventive Procedure (T061)
MSH D014611
SnomedCT 170310008, 147541002, 33879002
CPT 90749
LNC LP29692-8, MTHU000146
Dutch profylactische vaccinatie, vaccinatie, Vaccinatie
French Vaccination prophylactique, Vaccination
German prophylaktische Impfung, Impfung, Vakzination
Italian Vaccinazione profilattica, Vaccinazione
Portuguese Vacinação profiláctica, Vacinação
Spanish Vacunación profiláctica, inoculación, vacunación, Vacunación
Japanese ワクチン接種, 予防ワクチン接種, ワクチンセッシュ, ヨボウワクチンセッシュ
Swedish Vaccination
Czech očkování, vakcinace, Vakcinace, Preventivní očkování
Finnish Rokotus
Russian VAKTSINATSIIA, IMMUNIZATSIIA AKTIVNAIA, ВАКЦИНАЦИЯ, ИММУНИЗАЦИЯ АКТИВНАЯ
English vaccinations, vaccinations (medication), vaccinations [use for free text], Prophylactic vaccination, VACCIN, immunisation, inoculations, active immunization, immunization, vaccination, inoculation, Vaccine, Vaccinations, Inoculations - prophylactic, Inoculation, Vaccination, NOS, Inoculation, NOS, Vaccination, Vaccination NOS
Croatian CIJEPLJENJE
Polish Uodpornianie czynne, Szczepienia BCG, Szczepienia ochronne
Hungarian Prophylactikus vakcináció, Vakcináció
Norwegian Vaksinasjon, Vaksinasjoner

Ontology: Vaccines (C0042210)

Definition (NCI) Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response. Vaccines range from inactivated or attenuated microorganisms (bacteria and viruses), enhanced autologous tumor cells, tumor antigens or epitopes that are used to elicit host immune responses. Vaccines are used for the prevention, amelioration, or treatment of infectious diseases and cancer.
Definition (NCI_NCI-GLOSS) A substance or group of substances meant to cause the immune system to respond to a tumor or to microorganisms, such as bacteria or viruses. A vaccine can help the body recognize and destroy cancer cells or microorganisms.
Definition (MSH) Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa, or rickettsiae), antigenic proteins derived from them, or synthetic constructs, administered for the prevention, amelioration, or treatment of infectious and other diseases.
Definition (CSP) prophylactic or therapeutic preparation given to produce immune response to pathogenic organisms or substances; vaccines are used not only in infectious disease prevention and treatment, but in neoplastic and autoimmune disease treatment, control of fertility, drug abuse control etc.
Concepts Pharmacologic Substance (T121) , Immunologic Factor (T129)
MSH D014612
SnomedCT 71181003, 398827000
LNC LP30374-0, MTHU014526, LA20283-0
Swedish Vacciner
Czech vakcíny
Finnish Rokotteet
Russian VAKTSINY, ВАКЦИНЫ
English vaccines (medication), vaccines, [IM100] VACCINES, Vaccines [Chemical/Ingredient], vaccine, vaccine product, VACCINES, Vaccine (product), Vaccine (substance), Vaccine, Vaccine, NOS, Vaccines
Croatian CJEPIVA
Polish Szczepionki
Spanish vacuna (producto), vacuna (sustancia), vacuna, Vacunas
French Vaccins
German Impfstoffe, Vakzine
Italian Vaccini
Portuguese Vacinas